University of Maryland School of Medicine researchers engineered a new protein therapy that rapidly and selectively removes carbon monoxide (CO) from the bloodstream during acute poisoning episodes. Published in PNAS, the protein blocks viral replication mechanisms critical for CO’s latent phases, offering a safer and potentially more effective treatment compared to existing options. This breakthrough opens prospects for emergency care in CO exposure cases.